201 related articles for article (PubMed ID: 32775461)
1. Suboptimal Blood Pressure Control, Associated Factors, and Choice of Antihypertensive Drugs among Type 2 Diabetic Patients at KCMC, Tanzania.
Mbwete GW; Kilonzo KG; Shao ER; Chamba NG
J Diabetes Res; 2020; 2020():4376251. PubMed ID: 32775461
[TBL] [Abstract][Full Text] [Related]
2. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
[TBL] [Abstract][Full Text] [Related]
3. Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.
Chew BH; Mastura I; Shariff-Ghazali S; Lee PY; Cheong AT; Ahmad Z; Taher SW; Haniff J; Mustapha FI; Bujang MA
Cardiovasc Diabetol; 2012 May; 11():54. PubMed ID: 22607105
[TBL] [Abstract][Full Text] [Related]
4. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
5. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.
Adejumo O; Okaka E; Iyawe I
Malawi Med J; 2017 Jun; 29(2):113-117. PubMed ID: 28955417
[TBL] [Abstract][Full Text] [Related]
6. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
7. Drug utilization and blood pressure control in ambulatory hypertensive patients: focus on those with compelling indications.
Adedapo AD; Akunne OO; Oladapo OO; Salako BL
Int J Clin Pharmacol Ther; 2017 Mar; 55(3):237-245. PubMed ID: 27509827
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes.
Andros V; Egger A; Dua U
J Manag Care Pharm; 2006 May; 12(4):303-9. PubMed ID: 16792436
[TBL] [Abstract][Full Text] [Related]
9. Prescription of pharmacotherapy and blood pressure control among hypertensive outpatients in two semi-urban hospitals in Cameroon: a cross-sectional study.
Dzudie A; Fomo MF; Teuwafeu DG; Nkoke C; Kenfack A; Bonghaseh DT; Ekaney D; Tantchou A; Tantchou C; Ngoa LSE; Kengne AP; Choukem SP
Pan Afr Med J; 2020; 37():122. PubMed ID: 33425155
[TBL] [Abstract][Full Text] [Related]
10. [Control of blood pressure in diabetic patients in primary care setting. DIAPA study].
García Vallejo O; Vicente Lozano J; Vegazo O; Jiménez Jiménez FJ; Llisterri Caro JL; Redón J;
Med Clin (Barc); 2003 Apr; 120(14):529-34. PubMed ID: 12724064
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive Treatment Patterns and Blood Pressure Control in Older Adults: Results from the Berlin Aging Study II.
König M; Gollasch M; Rosada A; Demuth I; Spira D; Steinhagen-Thiessen E
Drugs Aging; 2018 Nov; 35(11):993-1003. PubMed ID: 30187292
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome: treatment of hypertensive patients.
Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
[TBL] [Abstract][Full Text] [Related]
13. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal protection in type 2 diabetes mellitus: the role of calcium channel blockers.
Nosadini R; Tonolo G
J Am Soc Nephrol; 2002 Nov; 13 Suppl 3():S216-23. PubMed ID: 12466317
[TBL] [Abstract][Full Text] [Related]
15. Drug management for hypertension in type 2 diabetes in family practice.
Putnam W; Buhariwalla F; Lacey K; Goodfellow M; Goodine RA; Hall J; Macdonald I; Murray M; Smith P; Burge F; Natarajan N; Lawson B
Can Fam Physician; 2009 Jul; 55(7):728-34. PubMed ID: 19602663
[TBL] [Abstract][Full Text] [Related]
16. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
17. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
[TBL] [Abstract][Full Text] [Related]
18. Patterns of antihypertensive therapy among patients with diabetes.
Johnson ML; Singh H
J Gen Intern Med; 2005 Sep; 20(9):842-6. PubMed ID: 16117753
[TBL] [Abstract][Full Text] [Related]
19. Thailand diabetes registry project: prevalence of hypertension, treatment and control of blood pressure in hypertensive adults with type 2 diabetes.
Bunnag P; Plengvidhya N; Deerochanawong C; Suwanwalaikorn S; Kosachunhanun N; Benjasuratwong Y; Krittiyawong S; Leelawatana R; Pratipanawatr T; Ngarmukos C; Chetthakul T; Puavilai G; Mongkolsomlit S; Rawdaree P
J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S72-7. PubMed ID: 17715837
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hypertension, control of blood pressure and treatment in hypertensive with type 2 diabetes in Hospital University Sains Malaysia.
Abougalambou SS; Abougalambou AS; Sulaiman SA; Hassali MA
Diabetes Metab Syndr; 2011; 5(3):115-9. PubMed ID: 22813562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
